Continuation study for anifrolumab beneficiaries
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial lets people who completed a prior anifrolumab study and saw benefit continue receiving the drug. It monitors long-term safety and effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You finished a previous anifrolumab study and received at least one dose
- Your doctor believes continuing anifrolumab is safe and beneficial for you
- You agree to follow contraception rules for 16 weeks after the last dose
- You are not pregnant, breastfeeding, or planning pregnancy
- You have no serious side effects from the previous study that would stop treatment
- You did not stop the parent study early
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well anifrolumab works for people with systemic lupus erythematosus (SLE) who are starting it for the first time. It aims to see if patients can achieve a low disease activity state (LLDAS5) after treatment.
This trial tests if a new drug called anifrolumab can help treat lupus in people who haven't taken strong medications like biologics or immunosuppressants before. It looks at overall disease activity and the chance to reduce steroid use.
This study looks at how well anifrolumab works for people with lupus in everyday medical care, not just in a research lab. It may help you if your doctor has decided to prescribe anifrolumab for the first time.
This study tracks how well anifrolumab works and how safe it is for people with active lupus. It's a real-world look at the drug's effects, so no additional treatments or tests are required beyond what your doctor already prescribes.
This trial tests anifrolumab, an investigational drug that may help reduce lupus activity in people with moderate-to-severe disease. If you have active lupus despite current treatments, this study might offer a new option.
This trial tests anifrolumab, given as a shot under the skin or through a vein, to see how it works in people with lupus. It may help if you have active lupus symptoms and are on standard treatments.
Hear when a new Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.